GM2A and Alzheimer disease: A targeted mass spectrometry study investigating AD and PD revealed significantly altered concentrations of proteins such as cathepsin B, cathepsin F, GM2 activator protein (GM2A), lysosome-associated membrane protein 2, AP2B1, and ubiquitin in the CSF of PD patients [133].